p110α RNAi inhibited growth and promoted apoptosis in all tested estrogen receptor positive (ER+) breast cancer cells under estrogen-deprived conditions, whereas p110β RNAi only affected cells harboring PIK3CB amplification. Here, PIK3CB is linked to breast carcinoma.